World leader in industrial microbiology selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, January 8, 2008 – clinivation, Inc. announced today that bioMérieux, Inc. has selected clinivation WorldView® Online Regulatory Intelligence web service.
“bioMérieux is clearly a world leader in biological diagnostics and we are delighted they have selected clinivation WorldView for international regulatory intelligence,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “With comprehensive, authoritative, and up-to-date information, bioMérieux will be readily alerted of important updates to worldwide submission and approval processes,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About bioMérieux, Inc.
A world leader in the field of in vitro diagnostics for over 40 years, bioMérieux is present in more than 150 countries through 35 subsidiaries and a large network of distributors. In 2006, revenues reached €1.037 billion with 83% of sales outside of France.
bioMérieux provides diagnostic solutions (reagents, instruments, software), which determine the source of disease and contamination to improve patient health and ensure consumer safety. Our products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on Eurolist by Euronext.
For more information, visit www.biomerieux-usa.com.
